Delivery Order SPE2DB22D6029-SPE2DB24FU1EG
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $3,154.75 to provide 4,564,781,462 ml of hydroxyzine 50 mg/ml vials to the Medical Supply Chain within the Defense agency. The contract has a June 4, 2024 completion date and was awarded on a full and open competition basis without any set-aside designations. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, to provide a specific medication - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract is a firm fixed price delivery order with a ceiling value of $15,835.11 and a performance period through March 20, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,024,994 milliliters of Hydroxyzine 50 mg/ml injectable solution. The $1,760.15 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government,...
- This federal contract award, with a ceiling value of $10,297.48, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract is for the delivery of hydroxyzine 10 mg/5 ml syrup, a prescription medication, with a completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, a $5,993.24 firm fixed price delivery order contract to supply Hydroxyzine 50 mg/mL medication vials. The contract has a performance period ending on May 17, 2022. Amerisourcebergen Drug Corp. holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,241.88 firm fixed-price delivery order for the supply of 4564707992 - Hydroxyzine 50 mg/ml vials. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC...
- This federal contract award, valued at $3,715.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565295944 - Hydroxyzine 10 mg/5 ml syrup 473 ml to support military treatment programs and facilities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- This federal contract award, with ID SPE2DB22D2214|SPE2DB23FS6HM, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.35 Firm Fixed Price Delivery Order is for the supply of 4562280379 - Hydroxyzine 10 mg/5 ml Syrup 473 ml. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,538.86 firm fixed price delivery order is for the supply of 4,564,367,067 milliliters of 50 milligram per milliliter hydroxyzine vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of hydroxyzine 50 mg/mL vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,622.52, and has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU1EGDelivery Order
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,795,203 bottles of 473 mL Hydroxyzine 10 mg/5 mL Syrup. The contract, valued at $1,319.37, is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of June 5, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, without the use of any set-aside designations. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/4/24 |